Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II, Open-Label, Prospective Study of T Cell Receptor Alpha/Beta Depletion (A/B TCD) Peripheral Blood Stem Cell (PBSC) Transplantation for Children and Adults With Hematological Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05735717
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:03.269044+00:00
Published At
2026-04-06T00:00:00+00:00
Record Updated At
2026-04-06
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Hematologic Malignancy", "Acute Leukemia", "Remission", "Acute Myeloid Leukemia", "Acute Lymphoblastic Leukemia", "AML", "TP53", "Intrachromosomal Amplification of Chromosome 21", "Cytogenetic Abnormality", "CNS Leukemia", "Minimal Residual Disease", "Myelodysplasia", "Juvenile Myelomonocytic Leukemia", "Somatic Mutation", "PTPN11 Gene Mutation", "N-RAS Gene Amplification", "Neurofibromatosis 1", "NF1 Mutation", "CBL Gene Mutation", "Monosomy 7", "Chromosome Abnormality", "Fetal Hemoglobin", "Lymphoblastic Lymphoma", "High Grade Non-Hodgkin\u0027s Lymphoma, Adult"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-06"
protocolSection.identificationModule.nctId
"NCT05735717"
protocolSection.identificationModule.officialTitle
"Phase II, Open-Label, Prospective Study of T Cell Receptor Alpha/Beta Depletion (A/B TCD) Peripheral Blood Stem Cell (PBSC) Transplantation for Children and Adults With Hematological Malignancies"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Hematologic Malignancy (protocolSection.conditionsModule.conditions)
  • Acute Leukemia (protocolSection.conditionsModule.conditions)
  • Remission (protocolSection.conditionsModule.conditions)
  • Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Acute Lymphoblastic Leukemia (protocolSection.conditionsModule.conditions)
  • AML (protocolSection.conditionsModule.conditions)
  • TP53 (protocolSection.conditionsModule.conditions)
  • Intrachromosomal Amplification of Chromosome 21 (protocolSection.conditionsModule.conditions)
  • Cytogenetic Abnormality (protocolSection.conditionsModule.conditions)
  • CNS Leukemia (protocolSection.conditionsModule.conditions)
  • Minimal Residual Disease (protocolSection.conditionsModule.conditions)
  • Myelodysplasia (protocolSection.conditionsModule.conditions)
  • Juvenile Myelomonocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Somatic Mutation (protocolSection.conditionsModule.conditions)
  • PTPN11 Gene Mutation (protocolSection.conditionsModule.conditions)
  • N-RAS Gene Amplification (protocolSection.conditionsModule.conditions)
  • Neurofibromatosis 1 (protocolSection.conditionsModule.conditions)
  • NF1 Mutation (protocolSection.conditionsModule.conditions)
  • CBL Gene Mutation (protocolSection.conditionsModule.conditions)
  • Monosomy 7 (protocolSection.conditionsModule.conditions)
  • Chromosome Abnormality (protocolSection.conditionsModule.conditions)
  • Fetal Hemoglobin (protocolSection.conditionsModule.conditions)
  • Lymphoblastic Lymphoma (protocolSection.conditionsModule.conditions)
  • High Grade Non-Hodgkin's Lymphoma, Adult (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.